Novartis Aktie
111,50
EUR
+1,35
EUR
+1,23
%
104,88
CHF
+0,86
CHF
+0,83
%
Werbung
Novartis Aktie Analyse
11.10.05 | Novartis Neutral | Oppenheimer | |
05.10.05 | Novartis neutral | Susquehanna Financial | |
04.10.05 | Novartis Neutral | Susquehanna Financial | |
03.10.05 | Novartis market perform | Piper Jaffray | |
21.09.05 | Novartis neutral | Bank Sarasin & Cie | |
15.09.05 | Novartis halten | Wertpapier | |
09.09.05 | Novartis hold | Deutsche Bank | |
02.09.05 | Novartis average | Caris & Company | |
Werbung
|
|||
02.09.05 | Novartis Average | Caris & Company | |
01.09.05 | Novartis halten | National-Bank AG | |
01.09.05 | Novartis hold | SEB | |
31.08.05 | Novartis peer perform | Thomas Weisel Partners | |
31.08.05 | Novartis Peer Perform | Thomas Weisel Partners | |
26.08.05 | Novartis halten | National-Bank AG | |
09.08.05 | Novartis neutral | Nasd@q Inside | |
21.07.05 | Novartis halten | National-Bank AG | |
13.07.05 | Novartis neutral | HypoVereinsbank | |
12.07.05 | Novartis in-line | Goldman Sachs | |
11.07.05 | Novartis neutral | Bank Sarasin & Cie | |
22.06.05 | Novartis neutral | Bank Sarasin & Cie | |
16.06.05 | Novartis neutral | Robert W. Baird | |
10.06.05 | Novartis halten | Fuchsbriefe | |
08.06.05 | Novartis neutral | HypoVereinsbank | |
07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
02.06.05 | Novartis neutral | Bank Sarasin & Cie | |
20.05.05 | Novartis | JRC | |
20.05.05 | Novartis | JRC | |
27.04.05 | Novartis Sector Perform | Vontobel | |
22.04.05 | Novartis Hold | SEB | |
21.04.05 | Novartis Neutral | Sarasin Research | |
18.04.05 | Novartis Neutral | JP Morgan | |
15.04.05 | Novartis Neutral | HypoVereinsbank | |
15.04.05 | Novartis Neutral | Sarasin Research | |
13.04.05 | Novartis Neutral | Sarasin Research | |
21.03.05 | Novartis Neutral | Sarasin Research | |
18.03.05 | Novartis Neutral | Sarasin Research | |
11.03.05 | Novartis Neutral | Sarasin Research | |
10.03.05 | Novartis Neutral | Sarasin Research | |
07.03.05 | Novartis Neutral | Sarasin Research | |
21.02.05 | Novartis Neutral | Sarasin Research | |
21.02.05 | Novartis Hold | SEB | |
26.01.05 | Novartis Market Perform | William Blair | |
25.01.05 | Novartis Halten | LB Baden-Württemberg | |
24.01.05 | Novartis Neutral | Sarasin Research | |
24.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Novartis Neutral | HypoVereinsbank | |
20.01.05 | Novartis Hold | SEB | |
20.01.05 | Novartis Neutral | Sarasin Research | |
19.01.05 | Novartis Equal-weight | Morgan Stanley | |
12.01.05 | Novartis Hold | Smith Barney Citigroup |
Werbung
Werbung